Strand Therapeutics: Funding, Investors & Team (Oct 2026)
Strand Therapeutics is a company that uses a biotechnology platform to develop gene therapies with the help of synthetic biology. Their products include immunotherapies that assist cells in producing specific cancer-fighting proteins, leading to improved immune system response in cancer patients.
Strand Therapeutics has raised $153M across 1 funding round on record, the most recent a Series B of $153M announced in Aug 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Strand Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Strand Therapeutics Funding Rounds
Strand Therapeutics Founders and Leadership Team
Contact details for the Strand Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Strand Therapeutics Funding Compared to Other Biotechnology Startups
Strand Therapeutics' latest round of $153M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Strand Therapeutics in Biotechnology and Cambridge
Companies Similar to Strand Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Strand Therapeutics Funding FAQs
What does Strand Therapeutics do?
Strand Therapeutics is a company that uses a biotechnology platform to develop gene therapies with the help of synthetic biology. Their products include immunotherapies that assist cells in producing specific cancer-fighting proteins, leading to improved immune system response in cancer patients.
How much funding has Strand Therapeutics raised?
Strand Therapeutics has raised $153M across 1 round on record. The most recent is a Series B of $153M announced in Aug 2025.
When did Strand Therapeutics last raise funding?
Strand Therapeutics' most recent funding round on record is a Series B of $153M, announced in Aug 2025.
Who founded Strand Therapeutics?
FundedIQ lists Ron Weiss (Founder) at Strand Therapeutics.
Where is Strand Therapeutics headquartered?
Strand Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Strand Therapeutics have?
Strand Therapeutics is in the 101-250 employee band.
How does Strand Therapeutics' funding compare to other Biotechnology startups?
Strand Therapeutics' latest round of $153M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Strand Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Strand Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.